Non-viral vectors for chimeric antigen receptor immunotherapy

Sandy Tretbar(Fraunhofer Research Institution for Materials Recycling and Resource Strategies IWKS), Ulrich Blache(Innovation Cluster (Canada)), Joel G. Rurik(Karolinska Institutet), Even H Rustad(Memorial Sloan Kettering Cancer Center), Zoltán Ivics(German Cancer Research Center), Duran Sürün(University Hospital Carl Gustav Carus), Stephan Fricke(Fraunhofer Research Institution for Materials Recycling and Resource Strategies IWKS), Frank Buchholz(Max Planck Society), Ulrike Köhl(Fraunhofer Research Institution for Materials Recycling and Resource Strategies IWKS), Johanna Olweus(Oslo University Hospital)
Nature Reviews Methods Primers
October 10, 2024
10.1038/s43586-024-00348-w
Cited by 12

Related Papers

A Human Interactome in Three Quantitative Dimensions Organized by Stoichiometries and Abundances
|Cell|2015|1.4k
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|799
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
|Science|2016|448
Immune Cells and Immunotherapy for Cardiac Injury and Repair
|Circulation Research|2021|269